Marios Arvanitis
Impact in
- Microbiology top 0.5%
- Actinomycetales infections and treatment
-
- Antibiotic Use and Resistance
Papers in
- Aging 2
- Co-authors
- Eleftherios MylonakisTheodora AnagnostouTheodoros KarantanosChristos GrigorasStyliani KaranikaAngela M. CaliendoBeth Burgwyn FuchsCharles J. Lowenstein
- Journals
- Clinical Infectious Diseases (4 papers)PLoS ONE (3 papers)Circulation (2 papers)Circulation Heart Failure (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesGreeceUnited Kingdom
In The Last Decade
Marios Arvanitis
40 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 127
- Microbiology 111
- Applied Microbiology and Biotechnology 140
- Molecular Medicine 316
- Infectious Diseases 633
- Endocrinology 127
Countries citing papers authored by Marios Arvanitis
This map shows the geographic impact of Marios Arvanitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marios Arvanitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marios Arvanitis more than expected).
Fields of papers citing papers by Marios Arvanitis
This network shows the impact of papers produced by Marios Arvanitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marios Arvanitis. The network helps show where Marios Arvanitis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marios Arvanitis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 42 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 8 | |
| 10 | 2020 | 11 | |
| 11 | 2019 | 175 | |
| 12 | 2016 | 332 | |
| 13 | 2015 | 77 | |
| 14 | 2014 | 28 | |
| 15 | 2014 | 41 | |
| 16 | 2014 | 63 | |
| 17 | 2013 | 18 | |
| 18 | 2013 | 93 | |
| 19 | 2005 | 4 | |
| 20 | 1996 | 48 |
About Marios Arvanitis
Marios Arvanitis is a scholar working on Microbiology, Aging, Infectious Diseases, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (9 papers), Genetic Associations and Epidemiology (6 papers), Fungal Infections and Studies (5 papers), Plant Pathogens and Fungal Diseases (4 papers), Lipoproteins and Cardiovascular Health (3 papers), Genetic Mapping and Diversity in Plants and Animals (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Microbiology (111 citations), Applied Microbiology and Biotechnology (140 citations), Molecular Medicine (316 citations), Infectious Diseases (633 citations) and Endocrinology (127 citations). Marios Arvanitis has collaborated with scholars based in United States, Greece and United Kingdom. Frequent co-authors include Eleftherios Mylonakis, Theodora Anagnostou, Theodoros Karantanos, Christos Grigoras, Styliani Karanika, Angela M. Caliendo, Beth Burgwyn Fuchs, Charles J. Lowenstein, Justin Glavis‐Bloom and Alexis Battle. Their work appears in journals such as Clinical Infectious Diseases, PLoS ONE, Circulation, Circulation Heart Failure and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.